VEGFR2/CD309 Antikörper (pTyr1214)
Kurzübersicht für VEGFR2/CD309 Antikörper (pTyr1214) (ABIN7303694)
Target
Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pTyr1214
-
Verwendungszweck
- Rabbit polyclonal antibody to VEGFR2 (Phospho-Y1214)
-
Spezifität
- Recognizes endogenous levels of VEGFR2 protein only when phosphorylated at Y1214.
-
Produktmerkmale
- Rabbit polyclonal antibody to VEGFR2 (pY1214)
-
Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding Y1214 of human VEGFR2 protein. The exact sequence is proprietary.
-
-
anti-VEGF Receptor 2 (VEGFR2) (AA 20-244) antibody
VEGFR2 Reaktivität: Maus, Ratte WB, IHC, FACS, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 20-242) antibodyVEGFR2 Reaktivität: Human WB, IHC, FACS, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (pTyr951) antibodyVEGFR2 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356), (C-Term) antibodyVEGFR2 Reaktivität: Human WB, FACS, IF, IHC (p) Wirt: Kaninchen Polyclonal RB01536 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356) antibodyVEGFR2 Reaktivität: Human WB, IHC, ELISA, FACS, IF Wirt: Kaninchen Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 101-200) antibodyVEGFR2 Reaktivität: Human, Maus, Ratte, Kaninchen ELISA, FACS, IHC (p), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (pTyr1214) antibodyVEGFR2 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1225-1356) antibodyVEGFR2 Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 1A9A3 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 20-764) antibodyVEGFR2 Reaktivität: Human ELISA, FACS, ICC Wirt: Maus Monoclonal 4B4 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 454-469), (Middle Region) antibodyVEGFR2 Reaktivität: Human WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB (1/500 - 1/1000), IH (1/100 - 1/200), IF/IC (1/100 - 1/500)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Andere Bezeichnung
- VEGFR2
-
Hintergrund
- FLK1, VEGFR2, Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, FLK-1, Kinase insert domain receptor, KDR, Protein-tyrosine kinase receptor flk-1, CD309
-
Gen-ID
- 3791, 25589
-
UniProt
- P35968
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-
